Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback